Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Mingde Biotech Co., Ltd., operating under the brand EasyDiagnosis, is a leading Chinese medical technology company specializing in the development and manufacture of in vitro diagnostic (IVD) solutions. Founded in 2008 and headquartered in Wuhan, the company has established a comprehensive product portfolio spanning point-of-care testing (POCT), molecular diagnostics, chemiluminescence, and clinical chemistry. EasyDiagnosis is particularly recognized for its rapid diagnostic kits targeting cardiovascular diseases, infectious diseases, and inflammatory markers, playing a critical role in emergency medicine and critical care. The company also provides integrated solutions for medical information systems and laboratory automation to enhance clinical efficiency. With a strong presence in both domestic and international markets, EasyDiagnosis continues to expand its technological capabilities in high-throughput sequencing and mobile healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EasyDiagnosis.